FDA Matters. There are no applications or other proceedings presently pending before the United States Food and Drug Administration ("FDA"). The FDA has not delivered a letter of nonapproval, or threatened to deliver such a letter, with respect to any product manufactured, marketed, licensed or developed by the Company, or any product which the Company intends to manufacture, market, license or develop.
Appears in 3 contracts
Samples: Stock Purchase Agreement (Ophidian Pharmaceuticals Inc), Stock Purchase Agreement (Ophidian Pharmaceuticals Inc), Stock Purchase Agreement (Ophidian Pharmaceuticals Inc)
FDA Matters. There Except as disclosed to the Purchaser in writing, there are no applications or other proceedings presently pending before the United States Food and Drug Administration (the "FDA"). The FDA has not delivered a letter of nonapproval, non-approval or threatened to deliver such a letter, letter with respect to any product manufactured, marketed, licensed or developed by the CompanyCompany or any Subsidiary, or any product which the Company intends or its Subsidiaries intend to manufacture, market, license or develop.
Appears in 2 contracts
Samples: D Equity Investment Agreement (Pharmacia & Upjohn Inc), Equity Investment Agreement (Miravant Medical Technologies)
